CureVac
Barbara Koegel-Hubbuch is a Senior Manager Internal Communications at CureVac since September 2022. Previously, Barbara worked as a Change & Culture Manager at Baxter from July 2016 to June 2022. With experience as a Communication Specialist at Gambro Dialysatoren GmbH and various roles in press and public relations at different healthcare institutions, Barbara has a diverse background in communication and healthcare. Barbara holds degrees in Systemic Coaching, Change Management, Organizational Development, Roman Philology, Art History, and Nursing for Internal Medicine and Intensive Care.
This person is not in any teams
CureVac
8 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.